Integrin beta 4 (ITGB4) and its tyrosine-1510 phosphorylation promote pancreatic tumorigenesis and regulate the MEK1-ERK1/2 signaling pathway
Pancreatic cancer is the fourth leading cause of cancer death, with a 5-year survival rate of only 1–4%. Integrin-mediated cell adhesion is critical for the initiation, progression, and metastasis of cancer. In this study we investigated the role of integrin b4 (ITGB4) and its phosphorylation at ty...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2020-02-01
|
Series: | Biomolecules & Biomedicine |
Subjects: | |
Online Access: | https://www.bjbms.org/ojs/index.php/bjbms/article/view/4255 |
_version_ | 1797260862987173888 |
---|---|
author | Xiangli Meng Peng Liu Yunhao Wu Xinlu Liu Yinpeng Huang Boqiang Yu Jiahong Han Haoyi Jin Xiaodong Tan |
author_facet | Xiangli Meng Peng Liu Yunhao Wu Xinlu Liu Yinpeng Huang Boqiang Yu Jiahong Han Haoyi Jin Xiaodong Tan |
author_sort | Xiangli Meng |
collection | DOAJ |
description |
Pancreatic cancer is the fourth leading cause of cancer death, with a 5-year survival rate of only 1–4%. Integrin-mediated cell adhesion is critical for the initiation, progression, and metastasis of cancer. In this study we investigated the role of integrin b4 (ITGB4) and its phosphorylation at tyrosine Y1510 (p-ITGB4-Y1510) in the tumorigenesis of pancreatic cancer. We analyzed the expression of ITGB4 and p-ITGB4-Y1510 in pancreatic cancer tissue and cell lines using immunohistochemistry, Western blot, or semi-quantitative reverse transcription PCR. ITGB4 and p-ITGB4-Y1510 were highly expressed in pancreatic cancer (n = 176) compared with normal pancreatic tissue (n = 171). High p-ITGB4-Y1510 expression correlated with local invasion and distant metastasis of pancreatic cancer, and high ITGB4 was significantly associated with poor survival of patients. Inhibition of ITGB4 by siRNA significantly reduced migration and invasion of PC-1.0 and AsPC-1 cells. Overexpression of the mutant ITGB4-Y1510A (a mutation of tyrosine to alanine at 1510 position) in PC-1.0 and AsPC-1 cells not only blocked the ITGB4 phosphorylation at Y1510 but also suppressed the expression of ITGB4 (p < 0.05 vs. wild-type ITGB4). The transfection of PC-1.0 and AsPC-1 cells with ITGB4-Y1510A significantly decreased the level of p-mitogen-activated protein kinase kinase (MEK)1 (T292) and p-extracellular signal-regulated kinase (ERK)1/2 but did not affect the level of p-MEK1 (T386) and p-MEK2 (T394). Overall, our study showed that ITGB4 and its phosphorylated form promote cell migration and invasion in pancreatic cancer and that p-ITGB4-Y1510 regulates the downstream MEK1-ERK1/2 signaling cascades. Targeting ITGB4 or its phosphorylation at Y1510 may be a novel therapeutic option for pancreatic cancer.
|
first_indexed | 2024-04-24T23:32:04Z |
format | Article |
id | doaj.art-0bcd14941a794f20922954a9679ba6a7 |
institution | Directory Open Access Journal |
issn | 2831-0896 2831-090X |
language | English |
last_indexed | 2024-04-24T23:32:04Z |
publishDate | 2020-02-01 |
publisher | Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina |
record_format | Article |
series | Biomolecules & Biomedicine |
spelling | doaj.art-0bcd14941a794f20922954a9679ba6a72024-03-15T14:30:09ZengAssociation of Basic Medical Sciences of Federation of Bosnia and HerzegovinaBiomolecules & Biomedicine2831-08962831-090X2020-02-0120110.17305/bjbms.2019.4255Integrin beta 4 (ITGB4) and its tyrosine-1510 phosphorylation promote pancreatic tumorigenesis and regulate the MEK1-ERK1/2 signaling pathwayXiangli Meng0https://orcid.org/0000-0002-3012-8385Peng Liu1https://orcid.org/0000-0001-8193-8997Yunhao Wu2Xinlu Liu3Yinpeng Huang4https://orcid.org/0000-0001-6206-2782Boqiang Yu5https://orcid.org/0000-0002-3558-8495Jiahong Han6Haoyi Jin7Xiaodong Tan8Department of the First General Surgery, Shengjing Hospital affiliated to China Medical University, Shenyang, ChinaDepartment of the First General Surgery, Shengjing Hospital affiliated to China Medical University, Shenyang, ChinaDepartment of the First General Surgery, Shengjing Hospital affiliated to China Medical University, Shenyang, ChinaDepartment of Anus and Intestine Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, ChinaMinimally Invasive Area of General Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, ChinaDepartment of General Surgery, Fushun Central Hospital, Fushun, ChinaDepartment of Surgery, Liaoning Electric Power Center Hospital, Shenyang, ChinaDepartment of the First General Surgery, Shengjing Hospital affiliated to China Medical University, Shenyang, ChinaDepartment of the First General Surgery, Shengjing Hospital affiliated to China Medical University, Shenyang, China Pancreatic cancer is the fourth leading cause of cancer death, with a 5-year survival rate of only 1–4%. Integrin-mediated cell adhesion is critical for the initiation, progression, and metastasis of cancer. In this study we investigated the role of integrin b4 (ITGB4) and its phosphorylation at tyrosine Y1510 (p-ITGB4-Y1510) in the tumorigenesis of pancreatic cancer. We analyzed the expression of ITGB4 and p-ITGB4-Y1510 in pancreatic cancer tissue and cell lines using immunohistochemistry, Western blot, or semi-quantitative reverse transcription PCR. ITGB4 and p-ITGB4-Y1510 were highly expressed in pancreatic cancer (n = 176) compared with normal pancreatic tissue (n = 171). High p-ITGB4-Y1510 expression correlated with local invasion and distant metastasis of pancreatic cancer, and high ITGB4 was significantly associated with poor survival of patients. Inhibition of ITGB4 by siRNA significantly reduced migration and invasion of PC-1.0 and AsPC-1 cells. Overexpression of the mutant ITGB4-Y1510A (a mutation of tyrosine to alanine at 1510 position) in PC-1.0 and AsPC-1 cells not only blocked the ITGB4 phosphorylation at Y1510 but also suppressed the expression of ITGB4 (p < 0.05 vs. wild-type ITGB4). The transfection of PC-1.0 and AsPC-1 cells with ITGB4-Y1510A significantly decreased the level of p-mitogen-activated protein kinase kinase (MEK)1 (T292) and p-extracellular signal-regulated kinase (ERK)1/2 but did not affect the level of p-MEK1 (T386) and p-MEK2 (T394). Overall, our study showed that ITGB4 and its phosphorylated form promote cell migration and invasion in pancreatic cancer and that p-ITGB4-Y1510 regulates the downstream MEK1-ERK1/2 signaling cascades. Targeting ITGB4 or its phosphorylation at Y1510 may be a novel therapeutic option for pancreatic cancer. https://www.bjbms.org/ojs/index.php/bjbms/article/view/4255ITGB4integrinMEK1 (T292)invasionmigrationpancreatic cancer |
spellingShingle | Xiangli Meng Peng Liu Yunhao Wu Xinlu Liu Yinpeng Huang Boqiang Yu Jiahong Han Haoyi Jin Xiaodong Tan Integrin beta 4 (ITGB4) and its tyrosine-1510 phosphorylation promote pancreatic tumorigenesis and regulate the MEK1-ERK1/2 signaling pathway Biomolecules & Biomedicine ITGB4 integrin MEK1 (T292) invasion migration pancreatic cancer |
title | Integrin beta 4 (ITGB4) and its tyrosine-1510 phosphorylation promote pancreatic tumorigenesis and regulate the MEK1-ERK1/2 signaling pathway |
title_full | Integrin beta 4 (ITGB4) and its tyrosine-1510 phosphorylation promote pancreatic tumorigenesis and regulate the MEK1-ERK1/2 signaling pathway |
title_fullStr | Integrin beta 4 (ITGB4) and its tyrosine-1510 phosphorylation promote pancreatic tumorigenesis and regulate the MEK1-ERK1/2 signaling pathway |
title_full_unstemmed | Integrin beta 4 (ITGB4) and its tyrosine-1510 phosphorylation promote pancreatic tumorigenesis and regulate the MEK1-ERK1/2 signaling pathway |
title_short | Integrin beta 4 (ITGB4) and its tyrosine-1510 phosphorylation promote pancreatic tumorigenesis and regulate the MEK1-ERK1/2 signaling pathway |
title_sort | integrin beta 4 itgb4 and its tyrosine 1510 phosphorylation promote pancreatic tumorigenesis and regulate the mek1 erk1 2 signaling pathway |
topic | ITGB4 integrin MEK1 (T292) invasion migration pancreatic cancer |
url | https://www.bjbms.org/ojs/index.php/bjbms/article/view/4255 |
work_keys_str_mv | AT xianglimeng integrinbeta4itgb4anditstyrosine1510phosphorylationpromotepancreatictumorigenesisandregulatethemek1erk12signalingpathway AT pengliu integrinbeta4itgb4anditstyrosine1510phosphorylationpromotepancreatictumorigenesisandregulatethemek1erk12signalingpathway AT yunhaowu integrinbeta4itgb4anditstyrosine1510phosphorylationpromotepancreatictumorigenesisandregulatethemek1erk12signalingpathway AT xinluliu integrinbeta4itgb4anditstyrosine1510phosphorylationpromotepancreatictumorigenesisandregulatethemek1erk12signalingpathway AT yinpenghuang integrinbeta4itgb4anditstyrosine1510phosphorylationpromotepancreatictumorigenesisandregulatethemek1erk12signalingpathway AT boqiangyu integrinbeta4itgb4anditstyrosine1510phosphorylationpromotepancreatictumorigenesisandregulatethemek1erk12signalingpathway AT jiahonghan integrinbeta4itgb4anditstyrosine1510phosphorylationpromotepancreatictumorigenesisandregulatethemek1erk12signalingpathway AT haoyijin integrinbeta4itgb4anditstyrosine1510phosphorylationpromotepancreatictumorigenesisandregulatethemek1erk12signalingpathway AT xiaodongtan integrinbeta4itgb4anditstyrosine1510phosphorylationpromotepancreatictumorigenesisandregulatethemek1erk12signalingpathway |